MedPath

FLUPENTIXOL DECANOATE INJECTION BP

FLUPENTIXOL DECANOATE INJECTION BP

Discontinued
DIN Number

02331713

Drug Class

Human

Market Date

N/A

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02331713
AIG Number0114584001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AF01 FLUPENTIXOL
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification28:16.08.32
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLUPENTIXOL DECANOATEActive
Strength: 20 MG / ML
Monograph: FLUPENTIXOL DECANOATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.